Name | Anumigilimab |
---|
Description | Anumigilimab (CSL-324) is an humanized IgG2a mAb against human granulocyte colony-stimulating factor (G-CSF) receptor. Anumigilimab can be used for increasing numbers of neutrophils at sites of inflammation[1][2]. |
---|---|
Related Catalog | |
Target |
granulocyte colony-stimulating factor (G-CSF) receptor[1] |
References |
No Any Chemical & Physical Properties |